Company Nyxoah SA

Equities

NYXH

BE0974358906

Advanced Medical Equipment & Technology

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Ratings for Nyxoah SA

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Advanced Medical Equipment & Technology

Market Closed - Euronext Bruxelles Other stock markets 11:36:05 2024-07-09 am EDT			5-day change	1st Jan Change
8.3 ^EUR	+4.53%		+22.78%	+94.84%

Jul. 03	Nyxoah Secures $40 Million Loan Facility from European Investment Bank	MT
Jul. 01	Nyxoah Submits Final Module of Premarket Approval Application for Sleep Apnea Therapy to FDA	MT

Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep disordered breathing conditions. Nyxoah SA's innovative solution platform is based on the Genio® system, a CE-Mark validated, user-centered neurostimulation therapy for obstructive sleep apnea, the world's most common sleep disordered breathing condition.

Number of employees: 147

EUR in Million	2022	Weight	2023	Weight	Delta
Hypoglossal Neurostimulations Therapy 100.0 %	3	100.0 %	4	100.0 %	+40.99%

EUR in Million	2022	Weight	2023	Weight	Delta
Germany 87.8 %	-	-	4	87.8 %	-
Switzerland 8.6 %	-	-	0	8.6 %	-
Austria 2.8 %	-	-	0	2.8 %	-
Spain 0.9 %	-	-	0	0.9 %	-

Managers	Title	Age	Since
Olivier Taelman CEO	Chief Executive Officer	54	19-06-30
Robert Taub FOU	Founder	78	09-07-14
Loïc Moreau DFI	Director of Finance/CFO	-	21-12-31
Jeyakumar Subbaroyan CTO	Chief Tech/Sci/R&D Officer	-	-
Bruno Onkelinx CTO	Chief Tech/Sci/R&D Officer	-	21-04-30
Roi Tsukran CTO	Chief Tech/Sci/R&D Officer	-	16-01-31
Inge Vanwittenbergh HRO	Human Resources Officer	-	-
Dorit Nahari PRN	Corporate Officer/Principal	-	19-12-31
Francis Kim LAW	General Counsel	-	Nov. 27
An Moonen LAW	General Counsel	-	20-11-30

Members of the board	Title	Age	Since
Kevin Rakin BRD	Director/Board Member	63	16-06-28
Robert Taub FOU	Founder	78	09-07-14
Jürgen Hambrecht BRD	Director/Board Member	77	15-12-31
Virginia Kirby BRD	Director/Board Member	67	22-06-07
Pierre Gianello BRD	Director/Board Member	68	18-03-26
Rita Johnson-Mills BRD	Director/Board Member	65	21-08-26
Daniel Wildman BRD	Director/Board Member	68	23-01-07
Olivier Taelman CEO	Chief Executive Officer	54	19-06-30

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	34,360,390	19,731,514 ( 57.43 %)	0	57.43 %

Name	Equities	%	Valuation
COCHLEAR LIMITED 16.39 %	5,631,319	16.39 %	39 M €
Taub Family 9.940 %	3,415,514	9.940 %	24 M €
Gilde Healthcare Partners BV 9.179 %	3,153,822	9.179 %	22 M €
Anneliese Monden 8.580 %	2,948,285	8.580 %	21 M €
RESMED, INC. 4.714 %	1,619,756	4.714 %	11 M €
Jürgen Hambrecht 3.984 %	1,369,000	3.984 %	10 M €
Deerfield Partners 2.617 %	899,300	2.617 %	6 M €
BNP Paribas Asset Management Belgium SA 2.306 %	792,365	2.306 %	6 M €
BlackRock Advisors LLC 1.889 %	648,987	1.889 %	5 M €
Olivier Taelman 1.222 %	419,930	1.222 %	3 M €

Nyxoah SA

Rue Edouard Belin 12

1435, Mont-Saint-Guibert

+32 10 22 23 55

http://www.nyxoah.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

8.3 EUR

Average target price

13.4 EUR

Spread / Average Target

+61.45%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
NYXOAH SA	+94.84%	296M
THERMO FISHER SCIENTIFIC	+0.20%	205B
DANAHER CORPORATION	+3.65%	178B
INTUITIVE SURGICAL, INC.	+31.11%	158B
BOSTON SCIENTIFIC CORPORATION	+32.35%	112B
SIEMENS HEALTHINEERS AG	+1.79%	64.58B
EDWARDS LIFESCIENCES CORPORATION	+22.60%	55.34B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-3.27%	46.64B
AGILENT TECHNOLOGIES, INC.	-9.79%	36.78B
GE HEALTHCARE TECHNOLOGIES INC.	-0.58%	34.85B

Other Advanced Medical Equipment & Technology